122 related articles for article (PubMed ID: 31273068)
1. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.
Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
5. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of Selected DNA Repair Genes and Lung Cancer in Chromium Exposure.
Halasova E; Matakova T; Skerenova M; Krutakova M; Slovakova P; Dzian A; Javorkova S; Pec M; Kypusova K; Hamzik J
Adv Exp Med Biol; 2016; 911():17-22. PubMed ID: 26987333
[TBL] [Abstract][Full Text] [Related]
8. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
9. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
[TBL] [Abstract][Full Text] [Related]
10. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.
Li G; Hu F; Yuan F; Fan J; Yu Z; Wu Z; Zhao X; Li Y; Li S; Rong J; Cui B; Dong X; Yuan H; Zhao Y
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1393-404. PubMed ID: 25560462
[TBL] [Abstract][Full Text] [Related]
11. VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients.
Camerin GR; Brito AB; Vassallo J; Derchain SF; Lima CS
Future Oncol; 2017 Feb; 13(5):409-414. PubMed ID: 27780361
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between hepatocellular carcinoma and the interaction between hMSH2 polymorphisms and environmental factors].
Tan S; Wang W; Liu S; Wei Q; Wei J; Wang Z; Yan M; Qiu X
Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):676-9. PubMed ID: 25369252
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair gene polymorphisms and association with lung cancer development.
Slováková P; Majerová L; Matáková T; Skereňová M; Kavcová E; Halašová E
Adv Exp Med Biol; 2015; 833():15-22. PubMed ID: 25252909
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.
Wang Y; Li G; Hu F; Bi H; Wu Z; Zhao X; Li Y; Li S; Li D; Cui B; Dong X; Zhao Y
Med Oncol; 2014 Jun; 31(6):975. PubMed ID: 24793746
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in hMSH2 and hMLH1 and response to platinum-based chemotherapy in advanced non-small-cell lung cancer patients.
Cheng H; Sun N; Sun X; Chen B; Li F; Feng J; Cheng L; Cao Y
Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):311-7. PubMed ID: 20458443
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
19. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumours.
Stasikowska-Kanicka O; Stawerski P; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(4):174-8. PubMed ID: 20072951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]